Literature DB >> 9859120

[Dementia screening in routine clinical practice. A comparative analysis of MMSE, SIDAM and ADAS].

M Burkart1, R Heun, W Maier, O Benkert.   

Abstract

Dementia-screening in clinical routine requires short, sensitive and specific tools. A number of standardized instruments are available for this purpose. The present study analysed the relationship between size of three exemplary dementia-screening tests and their diagnostic accuracy. The Mini-Mental-State-Examination (MMSE), the Structured Interview for the Diagnosis of Dementia of the Alzheimer-type, Multiinfarct Dementia and Dementias of other Aetiologies according to ICD-10 and DSM-III-R (SIDAM) and the Alzheimer's Disease Assessment Scale (ADAS) were applied to 71 patients with dementia of the Alzheimer-type and 73 non-demented controls. A ROC-analysis revealed that neither SIDAM nor ADAS differentiated better between demented and non-demented probands than the MMSE. This was also true for patients with mild dementia. In dementia staging the more comprehensive instruments did not surpass the MMSE, too. Due to it's brevity, the MMSE is the preferential screening-instrument for clinical routine.

Entities:  

Mesh:

Year:  1998        PMID: 9859120     DOI: 10.1007/s001150050373

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  3 in total

1.  A Validation Study of the Japanese Version of the Addenbrooke's Cognitive Examination-Revised.

Authors:  Kelssy Hitomi Dos Santos Kawata; Ryusaku Hashimoto; Yoshiyuki Nishio; Atsuko Hayashi; Nanayo Ogawa; Shigenori Kanno; Kotaro Hiraoka; Kayoko Yokoi; Osamu Iizuka; Etsuro Mori
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-03-02

2.  Prevalence of impaired functional reading ability and its association with quality of life, daily activity, mobility and social participation among general older adults in Germany.

Authors:  Franziska Radicke; Thea Schwaneberg; Claudia Meinke-Franze; Clemens Jürgens; Hans Jörgen Grabe; Wolfgang Hoffmann; Frank Tost; Neeltje van den Berg
Journal:  BMC Geriatr       Date:  2019-06-25       Impact factor: 3.921

3.  Cerebrospinal fluid melanin-concentrating hormone (MCH) and hypocretin-1 (HCRT-1, orexin-A) in Alzheimer's disease.

Authors:  Frank M Schmidt; Juergen Kratzsch; Hermann-Josef Gertz; Mandy Tittmann; Ina Jahn; Uta-Carolin Pietsch; Udo X Kaisers; Joachim Thiery; Ulrich Hegerl; Peter Schönknecht
Journal:  PLoS One       Date:  2013-05-07       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.